Mechanism and Management of Coronary Microvascular Angina Dingcheng Xiang, MD, Ph.D Cardiovascular Department Liuhuaqiao Hosptial Guangzhou, China 广州军区广州总医院心血管内科向定成.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Kulić M., Mujičić E., Šošević A., Gorani D.*, Tahirović E., Spužić M.
CORONARY CIRCULATION.
Cardiovascular Disaster in Hemodialysis patients
MEDPHARM DRUGS FOR ISCHEMIC HEART DISEASE FEBRUARY 10,2110.
The Late Sodium Current in the cardiac myocite: How viable as a new therapeutic target in angina? SPONSORED SATELLITE SESSION Dr Stephen Holmberg Lead.
CORONARY CIRCULATION DR. Eman El Eter.
CORONARY CIRCULATION DR. Eman El Eter.
ISCHEMIC HEART DISEASE. Coronary arteries  Left coronary artery supplies:  Left ventricle  Interventricular septum  Part of right ventricle.
Ischemic heart disease
Ischemic Heart Diseases IHD
By Dr. Zahoor 1. ISCHAEMIC HEART DISEASE (IHD) Why myocardial ischaemia occurs?  Myocardial Ischaemia occurs when there is less supply of oxygen to the.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
CORONARY CIRCULATION DR. Eman El Eter. Coronary Arteries The major vessels of the coronary circulation are: 1- left main coronary that divides into left.
Myocardial Ischemia Redefined: Optimal Care in CAD.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Ischemic Heart Diseases
Management of Stable Angina SIGN 96
Clinical case no. 22 Presenter: Lin,Huei-Hsiu (Caroline) (Caroline)
Coronary Artery Disease Presented by: Marissa V. Dacumos Batch 17
Vasospastic and Microvascular Coronary Artery Disease Attilio Maseri, MD University Vita-Salute San Raffaele – Milan, Italy 15th GWICC Beijing, October.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
Secondary Prevention & Cardiac Rehabilitation Malcolm Walker Consultant Cardiologist UCLH & the Heart Hospital, London.
Monitoring CAC and IMT: A useful clinical tool? Cardiology Service Walter Reed Army Medical Center Walter Reed Army Health Care System NO CONFLICTS TO.
BIMM118 Angina pectoris Medical term for chest pain or discomfort due to coronary heart disease. Typical angina pectoris (=“tight heart” is uncomfortable.
Silent Ischemia STABLE CAD
Roles of Nuclear Cardiology, Cardiac Computed Tomography Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease INT.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 12 Resistance-Training Strategies for Individuals with Coronary Heart Disease.
Clinical Management of Chronic Stable Angina. Anti-ischemic strategies in stable CAD Medical therapyPCICABG Initial therapy Recurrent ischemia TMREECPSCS.
Coronary Slow Flow Phenomenon 冠状动脉慢血流现象 Hui YongMing Beijing Fengtai Hospital Medical Center of FengTai District Teaching Hospital of Capital Medical University.
Innate immunity in cardiology: vessel (coronary spasm) and valve (aortic stenosis) Ming-Yow Hung, MD, FACC Division of Cardiology, Department of Internal.
Ischemic heart diseases Ischemia : it is inadequate supply of O2 to an organ or tissue (result from inadequate blood flow) insufficient to meet the organ’s.
 This disease Narrows the blood vessels that carry oxygen-rich blood to your heart. This happens because of plaque build up in the vessels.  The coronary.
Ischemic Heart Disease Dr. Ravi Kant Assistant Professor Department of General Medicine.
Pathophysiology of the coronary circulation: role of FFR Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy
Dr. Sohail Bashir Sulehria
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Internal Medicine Workshop Series Laos September /October 2009
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
الدكتور ياسين عبدالرضا الطويل أختصاص الطب الباطني كلية الطب/ جامعة الكوفة.
CARDIOVASCULAR EFFECTS OF COCAINE 1. TACHYCARDIA + HYPERTENSION 2. NON ISCHAEMIC CHEST PAIN 3. MYOCARDIAL ISCHAEMIA + INFARCTION 4. CORONARY ARTERY ANEURYSM.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy-associated plasma protein-A levels in.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Does acute improvement of endothelial dysfunction.
ANGINA PECTORIS Classic angina is characterized by substernal squeezing chest pain, occurring with stress and relieved with rest or nitroglycerin. May.
ISCHEMIC HEART DISEASE
THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Ischemic Heart Disease
Revascularization in Patients With Left Ventricular Dysfunction:
CORONARY ARTERY DISEASE
Atypical chest pain, atypical perfusion CMR scan
Cardiovascular Disease Coronary Heart Disease
The Role of Cardiac CT in Women
Takotsubo Cardiomyopathy (broken heart syndrome) Domina Petric, MD
Heart Health & Diabetes
Angina pectoris Domina Petric, MD.
Figure 2 Different manifestations of myocardial ischaemia
Resistant Hypertension: Initial Combinations of Medications
Coronary Artery Disease and Acute Coronary Syndrome
Pascal Meier, M. D. ; Rainer Zbinden, M. D. ; Mario Togni, M. D
Figure 6 The neurogenic components of angina
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
A 21st Century Approach to Stable Ischemic Heart Disease
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Mechanism and Management of Coronary Microvascular Angina Dingcheng Xiang, MD, Ph.D Cardiovascular Department Liuhuaqiao Hosptial Guangzhou, China 广州军区广州总医院心血管内科向定成

Definition Cardiac Syndrome X (1973, Kemp) Microvascular Angina (1986, Cannon) –Effort chest pain –Evidence of myocardial ischemia –No significant coronary artery stenosis

Mechanisms of Microvascular Angina Microvascular dysfunction Microvascular dysfunction – –Decreased reservation of arteriole dilation – –Arteriole spasm Myocardiac ischemia Myocardiac ischemia Effort angina Effort angina

Mechanisms of Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

Mechanisms of Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

Microvascular endothelial dysfunction (evidence 1) Coronary sinusPeripheral Venous ET1 ↑ and/or NO  Microvascular spasm Blood sample MVA patients

Microvascular endothelial dysfunction (evidence 2) Microvascular angina Patients Flow-Mediated-Dilation  Systemic endothelial dysfunction

Microvascular endothelial dysfunction (evidence 3) Ergonovine/Acetylcholine Test Coronary flow resistance ↑ (Myocardial perfusion  ) No epicardiac artery spasm Microvascular angina Patients

Mechanisms of Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

Arteriole Atherosclerosis Lacking in direct evidence –Limitation of angiographic resolution –No autopsy data: benign prognosis –No available animal model

Arteriole Atherosclerosis Indirect evidence –Angio/IVUS: mild stenosis in ischemia-related coronary arteries –Future PCI candidate vessel –Spotted scar in ischemia-related area –Accompanied by atherosclerotic risk factors –Anti-atherosclerosis therapy improved angina Am J Cardiol Jun 15;97(12):

Mechanisms of Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

Inflammation Increased inflammatory factors level during episode of angina –CRP –Interleukins Decreased during silence Future Cardiol Jan;2(1):63-73

Mechanisms of Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

spinal cord stimulation Reduced episode angina episode of angina Cardiac sympathetic nerves Autogenic training Sympathetic/para activity Menopause Jan-Feb;16(1):60-5 J Nucl Cardiol Nov-Dec;15(6):804-10

Mechanisms of Coronary Microvascular Dysfunction Endothelial dysfunction Arteriole atherosclerosis Inflammation Autonomic nerves dysfunction

Diagnosis of coronary microvascular angina Typic episodic effort chest pain Evidence of myocardial ischemia –ST  during chest pain –Positive stress test ( ECG/ECT/UCG) No significant coronary angiographic stenosis Negative ergonovine/acetylcholine test

Management of coronary microvascular angina Combined therapy –Life-style modification –Relieving chest pain –Preventing episode of chest pain –Improving endothelial function

Management of coronary microvascular angina Combined therapy –Life-style modification –Relieving chest pain –Preventing episode of chest pain –Improving endothelial function

Life-style modification Same risk factors of CHD Same life-style modification

Management of coronary microvascular angina Combined therapy –Life-style modification –Relieving chest pain –Preventing episode of chest pain –Improving endothelial function

Relieving chest pain Discontinue inducement Nitrates Spinal cord stimulation –Refractory chest pain Am J Med Jul;119(7):560-6 J Nucl Cardiol Nov-Dec;15(6):804-10

Management of coronary microvascular angina Combined therapy –Life-style modification –Relieving chest pain –Preventing episode of chest pain –Improving endothelial function

Preventing episode of angina Nitrates +  -blockers  reduce 80% of episodes  -blockers –Not as effective as in stenotic effort angina –nebivolol better than atenolol Am J Med Jul;119(7):560-6

Preventing episode of angina CCBs: Controversial Nicorandil Aminophylline or adenosine precursor –Effective but side-effect

Preventing episode of angina External counterpulsation –Reducing 87% of chest pain –Mechanism increasing myocardial perfusion Improving endothelial function Autogenic training Int J Cardiol Jun 26;135(2):256-7 Menopause Jan-Feb;16(1):60-5

Management of coronary microvascular angina Combined therapy –Life-style modification –Relieving chest pain –Preventing episode of chest pain –Improving endothelial function

Improving endothelial function Statins –Simvastatin & Xuezhikang –Decrease IL6,CRP,ET1 –Improve exercise-induced ischemia Cardiology. 2008;110(1):39-44 Int J Cardiol Oct 31;122(1):82-4

Improving endothelial function ACEI –Hypertension & microvascular angina –Enalapril: decrease blood pressure & improve endothelial function –Reduced episode of chest pain Am J Cardiol, 1995, 76: 31D

Improving endothelial function ARB –Irbesartan vs placebo:24 patients with 3w –No statistical improvement in ischemia and exercise tolerance Heart February; 93(2): 253–254.

Summary of management Life-style modification Nitrates+  -blockers+CCBs+ nicorandil StatinsAspirin ACEI/ARB: hypertension ? Refractory: EEP or spinal cord stimulation

Prognosis Depends on the left ventricular function Majority undergoes benign prognosis but poor life quality.

Conclusions Since initial report over 4 decades ago, microvascular angina continues to be a common occurrence for cardiologists. Despite considerable efforts over 4 decades, the syndrome remains controversial with regard to mechanism and management.